secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0001860742-24-000007
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb Q1 revenue $1.099B (+18% YoY); raises FY constant-currency growth guidance
--------------------------------------------------------------------------------

- GAAP net loss attributable widened to $167M from $90M; adjusted EBITDA rose to $180M from $141M.
- Vision Care revenue $635M (+8% reported, +11% constant currency); Surgical $197M (+8%); Pharmaceuticals $267M (+66% on XIIDRA/MIEBO).
- Raises FY constant-currency revenue growth guidance to 13-15% from 12-14%; revenue range now $4.600-$4.700B.
- Adjusted EPS (non-GAAP) $0.07 vs $0.10; GAAP EPS ($0.48) vs ($0.26).
- Cash from operations $41M vs use of $56M in Q1 2023; foreign-exchange headwind estimated at $90M for FY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000186074224000007/0001860742-24-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000186074224000007/blco-20240501.htm
  HTML page:      https://secwatch.observer/filing/0001860742-24-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer